2-Methyl-6-nitroquinoxaline

Catalog No.: 
ACLENF413
CAS No.: 
2942-02-1
Molecular Formula: 
C9H7N3O2
Molecular Weight: 
189.17
2-Methyl-6-nitroquinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$411.00InquiryInquiry
250mg95%$739.00InquiryInquiry
1g95%$2926.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-6-nitroquinoxaline
IUPAC Name2-methyl-6-nitroquinoxaline
MDL No.MFCD03695828
Molecular FormulaC9H7N3O2
Molecular Weight189.17
SMILESO=[N+](C1=CC=C2N=C(C)C=NC2=C1)[O-]
InChI KeyCZWQHNDESNJXGS-UHFFFAOYSA-N
SynonymQuinoxaline, 2-methyl-6-nitro-
CAS No.2942-02-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLENF413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDRJ419 route compound structure diagram
    ACIDRJ41999-56-9In Stock
  4. Then
  5. ACLENF413 route product structure diagram
    ACLENF4132942-02-1
Inquiry

2. ACLENF413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDRJ419 route compound structure diagram
    ACIDRJ41999-56-9In Stock
  4. Plus
  5. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  6. Then
  7. ACLENF413 route product structure diagram
    ACLENF4132942-02-1
Inquiry

3. ACLENF413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACIDRJ419 route compound structure diagram
    ACIDRJ41999-56-9In Stock
  4. Then
  5. ACLENF413 route product structure diagram
    ACLENF4132942-02-1
Inquiry

Comments (0)